Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.
Tapia MA, González-Navarrete I, Dalmases A, Bosch M, Rodriguez-Fanjul V, Rolfe M, Ross JS, Mezquita J, Mezquita C, Bachs O, Gascón P, Rojo F, Perona R, Rovira A, Albanell J.
Tapia MA, et al. Among authors: rojo f.
Cell Cycle. 2007 Sep 15;6(18):2284-92. doi: 10.4161/cc.6.18.4721. Epub 2007 Jul 10.
Cell Cycle. 2007.
PMID: 17890907
Free article.